CPO
Basic information
Region (hg38): 2:206939518-206969474
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 2 | 0 |
Variants in CPO
This is a list of pathogenic ClinVar variants found in the CPO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-206939612-C-G | not specified | Uncertain significance (Feb 05, 2025) | ||
2-206949646-T-C | not specified | Uncertain significance (Nov 08, 2024) | ||
2-206949653-G-T | not specified | Uncertain significance (Dec 26, 2023) | ||
2-206949657-G-T | not specified | Uncertain significance (Apr 26, 2024) | ||
2-206949671-C-A | not specified | Uncertain significance (Dec 06, 2023) | ||
2-206949693-A-G | not specified | Uncertain significance (Feb 18, 2025) | ||
2-206949699-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
2-206958311-C-T | not specified | Uncertain significance (Apr 12, 2023) | ||
2-206958323-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
2-206958358-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
2-206958367-T-G | not specified | Uncertain significance (Feb 07, 2025) | ||
2-206958397-G-C | not specified | Uncertain significance (Jul 16, 2024) | ||
2-206959635-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
2-206959644-A-G | not specified | Uncertain significance (Feb 09, 2022) | ||
2-206959649-G-C | not specified | Uncertain significance (Jun 11, 2024) | ||
2-206959655-T-A | not specified | Uncertain significance (Feb 14, 2025) | ||
2-206959664-C-T | not specified | Uncertain significance (Oct 29, 2024) | ||
2-206959665-G-A | not specified | Likely benign (Sep 20, 2024) | ||
2-206959668-A-C | not specified | Uncertain significance (Dec 27, 2023) | ||
2-206959674-T-G | not specified | Uncertain significance (Oct 09, 2024) | ||
2-206959719-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
2-206959725-T-G | not specified | Uncertain significance (Jul 19, 2022) | ||
2-206959730-A-G | not specified | Uncertain significance (Sep 30, 2024) | ||
2-206960873-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
2-206960879-C-T | not specified | Likely benign (Apr 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPO | protein_coding | protein_coding | ENST00000272852 | 9 | 29921 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.27e-21 | 0.000131 | 125528 | 1 | 209 | 125738 | 0.000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.479 | 183 | 202 | 0.905 | 0.0000101 | 2440 |
Missense in Polyphen | 50 | 53.933 | 0.92707 | 711 | ||
Synonymous | -0.375 | 80 | 75.8 | 1.05 | 0.00000404 | 705 |
Loss of Function | -1.32 | 27 | 20.5 | 1.32 | 0.00000102 | 247 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00751 | 0.00741 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000406 | 0.000404 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.000817 | 0.000817 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Carboxypeptidase which preferentially cleaves C-terminal acidic residues from peptides and proteins. Can also cleave C- terminal hydrophobic amino acids, with a preference for small residues over large residues. {ECO:0000269|PubMed:21921028}.;
Recessive Scores
- pRec
- 0.0942
Intolerance Scores
- loftool
- 0.917
- rvis_EVS
- 0.67
- rvis_percentile_EVS
- 84.61
Haploinsufficiency Scores
- pHI
- 0.0953
- hipred
- N
- hipred_score
- 0.219
- ghis
- 0.433
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.000726
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- proteolysis
- Cellular component
- extracellular space;apical plasma membrane;anchored component of plasma membrane
- Molecular function
- metallocarboxypeptidase activity;zinc ion binding